Dr. Donald R. Mattison co-authors: Adult Utilization of Psychiatric Drugs

December 12, 2016
Posted in

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least…

Read More

RSI welcomes Kannan Krishnan

December 12, 2016
Posted in

RSI is pleased to announce that Kannan Krishnan has recently accepted the position of Senior Vice President, Chemical Risk Assessment, effective July 1, 2016. Kannan will be responsible for conducting chemical risk assessment for our public and private sector clients. Such assessments may include the application of diverse methods and…

Read More

RSI launches game-changing climate app

June 30, 2016
Posted in

RSI launched the Climate Change Hazards Information Portal (CCHIP).

Read More

Climate change modelling for the Bow River watershed

June 29, 2016
Posted in

Following up on the recommendations put forth by the Expert Management Panel on River Flood Mitigation, the Environmental and Safety Management (ESM) and Water Resources (WS) business units of the City of Calgary are currently assessing how to best develop a suite of watershed-scale climate models to capture various weather event…

Read More

QuarterWatch analyzes MedWatch Reports

June 29, 2016
Posted in

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant…

Read More

Climate change modelling for the Bow River watershed

June 29, 2016
Posted in

Developing a suite of watershed-scale climate models.

Read More

QuarterWatch analyzes MedWatch Reports

June 29, 2016
Posted in

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant…

Read More